A Time-lapse Monitoring Prospective Study
Launched by ART FERTILITY CLINICS LLC · May 20, 2021
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
The use of extended embryo culture to the blastocyst stage and PGT-A has enabled identification and selection of embryos with the best developmental potential and improved IVF clinical outcomes. It is considered a routine practice to grade the embryos on day 3 of development, which will require disturbing the culture conditions by annotating the embryos using inverted microscopes. However, the application of Time-lapse technology (TLS) allows annotating the embryos on day 3 without interrupting the culture conditions, especially if TLS is combined with single-step culture medium.
There are...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with a minimum of 8 - 10 follicles during ovarian stimulation
- • Patients with a minimum of 8 mature oocytes
- • PGT-A
- • ICSI
- • BMI\<35
- • Age 18- 40
- • Fresh or frozen ejaculatory sperm \>10,000 motile sperm
- • Any Ovarian stimulation
- • Embryos cultured in Time-lapse system
- Exclusion Criteria:
- • PGT-M or PGT-SR
- • Previous history of embryo arrest
- • Endometriosis
- • Hydrosalpinx
- • History of uterine abnormality or previous uterine surgery
- • History of previous treatment which may impact the ovarian reserve (adnexal surgery, chemotherapy, radiation...)
About Art Fertility Clinics Llc
Art Fertility Clinics LLC is a leading provider of advanced reproductive healthcare services, specializing in assisted reproductive technologies to support individuals and couples facing fertility challenges. With a commitment to personalized care, state-of-the-art facilities, and a team of experienced specialists, the clinic offers a comprehensive range of services, including in vitro fertilization (IVF), egg freezing, and genetic testing. Art Fertility Clinics LLC is dedicated to advancing reproductive science through innovative clinical trials and research initiatives, ensuring patients receive the most effective and up-to-date treatment options available.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abu Dhabi, , United Arab Emirates
Abu Dhabi, , United Arab Emirates
Patients applied
Trial Officials
IBRAHIM ELKHATIB
Principal Investigator
ART Fertility Clinics LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials